云顶集团3118(中国)

    Crystallization of Zika virus NS2B-NS3 protease

    Peter Marples, Lizbé Koekemoer, Daren Fearon, xiaomin.ni Ni

    Published: 2024-04-26 DOI: 10.17504/protocols.io.eq2lyj51mlx9/v1
    AI 解读
    浏览 1561

    Disclaimer

    The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    Acknowledgements:

    Diamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot OX11 0QX, UK

    Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK

    Oxford Lab Technologies crystal shifter http://doi.org/10.1107/S2059798320014114

    Abstract

    Zika virus (ZIKV) infections causes microcephaly in new-borns and Guillain-Barre syndrome in adults raising a global public health concern, yet no vaccines or antiviral drugs are available to treat or prevent ZIKV infections. The viral NS3 protease with its NS2B cofactor is essential for the cleavage of Zika polyprotein precursor into individual structural and non-structural proteins and is therefore an attractive drug target. We optimized a robust crystal system of co-expressed NS3 protease with its NS2B cofactor and used this in a crystallographic fragment screening campaign.

    Steps

    Equipment needed

    1.

    Formulatrix Rock Imager (or incubator of choice)

    SPT mosquito

    Equipment

    ValueLabel
    Mosquito HVNAME
    High Volume 16-Channel Robotic Liquid HandlerTYPE
    SPT LabTechBRAND
    3097-01057SKU

    P100 8 multi-channel pipette

    SwissCI 3 lens plate

    Crystallization experiment

    2.

    Protein and buffer requirements:

    43.2µL``15mg/mL``Sample

    2.88mL

    3.

    Crystallisation screen composition:

    30% w/v PEG 2000

    0.2Molarity (M) Ammonium sulfate

    0.1Molarity (M) sodium acetate 4.8

    Stock solutions used:

    1Molarity (M) Ammonium sulfate

    1Molarity (M) Sodium acetate 4.8

    50% w/v PEG 2000

    Note
    The crystallisation screen can be stored in a duran bottle or aliquoted into 96 deep well block for easy dispensing into SwissCI 3 lens plates. For long term storage keep the Crystallisation screen in the fridge at 4°C.

    4.

    Dispense 30µL into SwissCI 3 lens plate reservoir wells using a 100 µl multi-channel pipette.

    Dispense 150nL``15mg/mL``Sample to each lens using the SPT mosquito.

    Dispense 150nL to each lens using the SPT mosquito.

    Drop ratio: 1:1

    Final drop volume: 300 nl

    5.

    Incubate at 20°C for 24h 0m 0s in Formulatrix Rock Imager.

    Imaging Schedule : The first images are taken after 12 h and the imaging schedule follows a Fibonacci sequence of days for further collections.

    6.

    Citation
    Crystals typically form within 12 h, within 24 h they have reached their maximum size with slight precipitant. Crystals form on their own and have cubic appearance. (see image below)Morphology: cubicSize: ~50 μm in length, width and depthAverage resolution: 1.7 ÅSpace group: P4322Unit cell: 43 Å, 43 Å, 217 Å 90.00°, 90.00°, 90.00°
    An example of a drop containing Zika NS2BNS3 crystals.
    An example of a drop containing Zika NS2BNS3 crystals.

    Data collection at Synchrotron

    7.

    Diamond Light Source

    Unattended Data Collection (UDC)

    Data Collection Temperature: 100K

    Detector: DECTRIS EIGER2 X 9M

    Beamline: I04-1

    Wavelength: 0.9212 Å

    Resolution (Å): 1.62

    Beam Size (μm): 60 X 50

    Number of images: 3600

    Oscillation: 0.10°

    Exposure (s): 0.0020

    Transmission (%): 100

    Flux (ph/s): 9.50e+11

    推荐阅读

    Nature Protocols
    Protocols IO
    Current Protocols
    扫码咨询